VASH2 and head and neck squamous cell carcinoma: After tumor resection, plasma VASH1 levels were significantly downregulated (2233 ± 1464 pg·mL−1 vs. 2425 ± 1493 pg·mL−1, p = 0.0085), while plasma VASH2 levels remained unchanged in HNSCC patients.